Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Total Costs & Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+21.0%
5Y CAGR+22.4%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+21.0%/yr
vs +42.7%/yr prior
5Y CAGR
+22.4%/yr
Consistent
Acceleration
-21.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$790.41M+8.1%
2025$731.10M+20.9%
2024$604.63M+35.6%
2023$445.74M+5.7%
2022$421.74M+46.8%
2021$287.32M+58.6%
2020$181.15M+68.3%
2019$107.61M+49.3%
2018$72.08M+5.4%
2017$68.40M-